Drug intelligence / Profile preview

sesaminol

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

**Sesaminol** is a naturally occurring lignan compound found primarily in sesame seeds (*Sesamum indicum*) and is a byproduct of sesame oil extraction. It belongs to the class of furanoid lignans and is characterized by a unique tetrahydrofuran-based structure. Sesaminol exhibits strong antioxidant properties, primarily by activating the Nrf2-ARE signaling pathway, which leads to nuclear translocation of Nrf2, enhanced expression of antioxidant enzymes (such as NQO1), and reduction of intracellular reactive oxygen species (ROS). Recent studies indicate that sesaminol demonstrates neuroprotective effects in cellular and animal models of Parkinson’s disease, reducing neuronal damage, enhancing dopamine levels, and preserving gastrointestinal function. It is not an approved pharmaceutical drug but has been studied for potential preventive and therapeutic roles as a dietary supplement, especially for neurodegenerative and oxidative stress-related conditions[3][4][5][6].

Other names
1,3-Benzodioxol-5-ol, 6-[(1S,3aR,4S,6aR)-4-(1,3-benzodioxol-5-yl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]6-[(1S,3aR,4S,6aR)-4-(1,3-benzodioxol-5-yl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-1-yl]-1,3-benzodioxol-5-ol(1S,3aβ,6aβ)-1β-(6-Hydroxy-1,3-benzodioxol-5-yl)-4β-(1,3-benzodioxol-5-yl)tetrahydro-1H,3H-furo[3,4-c]furan
02

Targets

NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)

Beyond the preview

Go deeper on sesaminol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sesaminol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call